130 related articles for article (PubMed ID: 14512000)
1. Long term angiotensin converting enzyme-inhibition in patients after coronary artery bypass grafting reduces levels of soluble intercellular cell adhesion molecule-1.
van Haelst PL; Tervaert JW; van Geel PP; Veeger NJ; Gurné O; Gans RO; van Gilst WH
Eur J Vasc Endovasc Surg; 2003 Oct; 26(4):387-91. PubMed ID: 14512000
[TBL] [Abstract][Full Text] [Related]
2. Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia.
Oosterga M; Voors AA; Pinto YM; Buikema H; Grandjean JG; Kingma JH; Crijns HJ; van Gilst WH
Am J Cardiol; 2001 Mar; 87(5):542-6. PubMed ID: 11230836
[TBL] [Abstract][Full Text] [Related]
3. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study.
Webb CM; Underwood R; Anagnostopoulos C; Bennett JG; Pepper J; Lincoln C; Collins P
Eur J Cardiothorac Surg; 1998 Jan; 13(1):42-8. PubMed ID: 9504729
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
van der Harst P; Voors AA; Volbeda M; Buikema H; van Veldhuisen DJ; van Gilst WH
Am J Cardiol; 2006 Jun; 97(12):1697-701. PubMed ID: 16765116
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial.
Cashin-Hemphill L; Holmvang G; Chan RC; Pitt B; Dinsmore RE; Lees RS
Am J Cardiol; 1999 Jan; 83(1):43-7. PubMed ID: 10073783
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.
Mancini GB; Henry GC; Macaya C; O'Neill BJ; Pucillo AL; Carere RG; Wargovich TJ; Mudra H; Lüscher TF; Klibaner MI; Haber HE; Uprichard AC; Pepine CJ; Pitt B
Circulation; 1996 Aug; 94(3):258-65. PubMed ID: 8759064
[TBL] [Abstract][Full Text] [Related]
7. Influence of smoking status on angiotensin-converting enzyme inhibition-related improvement in coronary endothelial function. TREND Investigators. Trial on Reversing Endothelial Dysfunction.
Schlaifer JD; Mancini GB; O'Neill BJ; Pitt B; Haber HE; Pepine CJ
Cardiovasc Drugs Ther; 1999 May; 13(3):201-9. PubMed ID: 10439882
[TBL] [Abstract][Full Text] [Related]
8. Ischemia Management with Accupril post bypass Graft via Inhibition of angiotensin coNverting enzyme (IMAGINE): a multicentre randomized trial - design and rationale.
Warnica JW; Gilst WV; Baillot R; Johnstone D; Block P; Myers MG; Chocron S; Ave SD; Martineau P; Rouleau JL
Can J Cardiol; 2002 Nov; 18(11):1191-200. PubMed ID: 12464983
[TBL] [Abstract][Full Text] [Related]
9. The QUinapril Ischemic Event Trial (QUIET) design and methods: evaluation of chronic ACE inhibitor therapy after coronary artery intervention.
Texter M; Lees RS; Pitt B; Dinsmore RE; Uprichard AC
Cardiovasc Drugs Ther; 1993 Apr; 7(2):273-82. PubMed ID: 8357782
[TBL] [Abstract][Full Text] [Related]
10. The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function.
Pitt B; O'Neill B; Feldman R; Ferrari R; Schwartz L; Mudra H; Bass T; Pepine C; Texter M; Haber H; Uprichard A; Cashin-Hemphill L; Lees RS;
Am J Cardiol; 2001 May; 87(9):1058-63. PubMed ID: 11348602
[TBL] [Abstract][Full Text] [Related]
11. Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators.
Pflugfelder PW; Baird MG; Tonkon MJ; DiBianco R; Pitt B
J Am Coll Cardiol; 1993 Nov; 22(6):1557-63. PubMed ID: 8227822
[TBL] [Abstract][Full Text] [Related]
12. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M
J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin converting enzyme inhibitors and restenosis: let's stop teasing ourselves.
Mancini GB
Cardiovasc Drugs Ther; 2001 Jul; 15(4):293-5. PubMed ID: 11800410
[No Abstract] [Full Text] [Related]
14. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery.
Rouleau JL; Warnica WJ; Baillot R; Block PJ; Chocron S; Johnstone D; Myers MG; Calciu CD; Dalle-Ave S; Martineau P; Mormont C; van Gilst WH;
Circulation; 2008 Jan; 117(1):24-31. PubMed ID: 18071079
[TBL] [Abstract][Full Text] [Related]
15. Quinapril with high affinity to tissue angiotensin-converting enzyme reduces restenosis after percutaneous transcatheter coronary intervention.
Okimoto T; Imazu M; Hayashi Y; Gomyo Y; Sekiguchi Y; Yanagihara K; Shimohara Y; Sumii K; Yamamoto H; Tadehara F; Toyofuku M; Kohno N
Cardiovasc Drugs Ther; 2001 Jul; 15(4):323-9. PubMed ID: 11800416
[TBL] [Abstract][Full Text] [Related]
16. Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.
Culy CR; Jarvis B
Drugs; 2002; 62(2):339-85. PubMed ID: 11817979
[TBL] [Abstract][Full Text] [Related]
17. Does blood pressure reduction necessarily compromise cardiac function or renal hemodynamics? Effects of the angiotensin-converting enzyme inhibitor quinapril.
Kjeldsen SE; Gupta RK; Krause L; Weder AB; Julius S
Am Heart J; 1992 May; 123(5):1433-8. PubMed ID: 1575171
[TBL] [Abstract][Full Text] [Related]
18. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
[TBL] [Abstract][Full Text] [Related]
19. Quinapril therapy in patients with chronic mitral regurgitation.
Schön HR; Schröter G; Barthel P; Schömig A
J Heart Valve Dis; 1994 May; 3(3):303-12. PubMed ID: 8087269
[TBL] [Abstract][Full Text] [Related]
20. Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial.
Pepine CJ; Rouleau JL; Annis K; Ducharme A; Ma P; Lenis J; Davies R; Thadani U; Chaitman B; Haber HE; Freedman SB; Pressler ML; Pitt B;
J Am Coll Cardiol; 2003 Dec; 42(12):2049-59. PubMed ID: 14680725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]